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Abstract
Background: Using the FIV model, we reported previously that CD4
+CD25
+ T regulatory (Treg) cells from FIV
+ cats
are constitutively activated and suppress CD4
+CD25
- and CD8
+ T cell immune responses. In an effort to further
explore Treg-mediated suppression, we asked whether Treg cells induce anergy through the alteration of
production of cyclins, cyclin-dependent kinases and their inhibitors.
Results: Lymphocytes were obtained from control or FIV
+ cats and sorted by FACS into CD4
+CD25
+ and CD8
+
populations. Following co-culture with CD4
+CD25
+ cells, CD8
+ targets were examined by Western blot for changes
in cyclins D3, E and A, retinoblastoma (Rb) protein, as well as the cyclin dependent kinase inhibitor p21
cip1.
Following co-culture with CD4
+CD25
+cells, we observed up-regulation of p21
cip1 and cyclin E, with down-
regulation of cyclin D3, in CD8
+ cells from FIV
+ cats. As expected, CD8
+ targets from control cats were quiescent
with little up-regulation of p21
cip1 and cyclin E. There was also a lack of Rb phosphorylation in CD8
+ targets
consistent with late G1 cell cycle arrest. Further, IL-2 mRNA was down regulated in CD8
+ cells after co-culture with
CD4
+CD25
+ Treg cells. Following CD4
+CD25
+ co-culture, CD8
+ targets from FIV
+ cats also had increased Foxp3
mRNA expression; however, these CD8
+Foxp3
+ cells did not exhibit suppressor function.
Conclusions: Collectively, these data suggest that CD4
+CD25
+ Treg cells from FIV
+ cats induce CD8
+ anergy by
disruption of normal G1 to S cell cycle progression.
Background
Using FIV as an AIDS lentivirus model, we reported pre-
viously that CD4
+CD25
+ Treg cells in both the acute
phase and long-term, asymptomatic phase of infection
are constitutively activated and suppress CD4
+CD25
- and
CD8
+ T cell immune responses [1-3]. Activated feline
Treg cells from FIV
+ cats suppress CD4
+ cell prolifera-
tion and IL-2 production and CD8
+ cell IFNg production
[1,3,4]. We have demonstrated preferential in vitro and
in vivo replication of FIV in the CD4
+CD25
+ subset, sug-
gesting a unique relationship between lentiviral infections
and Treg cell activation [4,5]. Impaired CD8
+ Tc e l l
immune responses are well described in AIDS lentivirus
infections and evidence suggests that this impairment
correlates with activation of CD4
+CD25
+ Treg cells [6-9].
Lentivirus infections are characterized by an early
increase in CD8
+ T lymphocyte numbers, and the qual-
ity of the CTL response is associated with a decline in
plasma viremia. A strong CTL response correlates with
clearance of virus from circulation, and a weaker
response is associated with poor or no control of viral
replication [10-15]. Experimental models and clinical
data from other types of viral infections have clearly
demonstrated that CD8
+ lymphocytes are critical for the
control of viral infection, and escape of this initial
response can lead to establishment and maintenance of
a persistent infection and may contribute to immune
exhaustion [16-22]. Using the FIV model we designed
experiments to identify lentiviral mechanism(s) used to
escape virus elimination and establish a chronic infec-
t i o ni nt h ef a c eo far o b u s tC D 8
+ response. These
experiments have focused on Treg cell activation
kinetics during FIV infection, the mechanism of Treg
mediated suppression, and identification of cells targeted
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established that Treg cells are able to suppress CD8
+
effector responses during both acute and chronic FIV
infection [1-3]. We therefore asked what intracellular
events occur in the CD8
+ target cell following interaction
with CD4
+CD25
+ Treg cells, do these intracellular events
contribute to CD8
+ anergy, and could these CD8
+ targets
be converted into CD8
+ suppressor cells?
Down-regulation of IL-2 production, loss of effector
function, and lack of proliferation are well described in
lymphocyte target cells following interaction with acti-
vated CD4
+CD25
+ Treg cells [1,23-25]. However, these
events are the end result of a complex process, includ-
ing interruption of cell cycling events, that may occur in
CD4
+CD25
- or CD8
+ target cells following their interac-
tion with CD4
+CD25
+ Treg cells. Cell cycle progression
is tightly regulated by proteins such as cyclins, cyclin
dependent kinases (CDKs) and cyclin dependent kinase
inhibitors (CDKIs) that ensure an appropriate and coor-
dinated cellular response. This mechanism responds to
intracellular and extracellular signals and will arrest cell
cycle progression (induce anergy) in response to adverse
intracellular or extracellular conditions [26]. During the
early immune response, primary T lymphocytes that
receive optimal stimulation through their TCR and co-
stimulatory pathways proceed through G1 cell cycle pro-
gression (Figure 1). Subsequent multiple cell divisions
are then required during this primary response for
optimal IL-2 and IFNg production and the avoidance of
anergy [27,28]. Responding to stimulation under favor-
able conditions, D cyclins are expressed sequentially
starting in late G0/early G1 during the normal progres-
sion of the cell cycle [28,29]. Next, Cyclin E emerges
during late G1 phase following degradation/sequestra-
tion of the CDKIs p27
Kip1 and p21
Cip1.T h eC D K I s
p27
Kip1 and p21
Cip1 are instrumental in a coordinated
G1 to S phase transition “holding” the cellular machin-
ery in place until the cyclins and CDKs are at the proper
levels and activation state. Cyclins partner with their
cyclin dependent kinase to sequentially phosphorylate
Rb during G1 progression. Hyperphosphorylation of Rb
and release of E2F transcription factors signals the irre-
versible commitment to S phase and cell cycle progres-
sion [28,29].
There are at least two broad categories of CD4
+CD25
+
Treg cells, natural Treg cells and adaptive (or induced)
Tregs [30,31]. Natural Treg cells originate in the thymus
and reside in peripheral lymph tissues to prevent auto-
immune responses [32,33]. Adaptive Treg cells are phe-
notypically indistinguishable from natural Treg cells and
modulate immune responses to microbial pathogens
including bacteria, viruses, fungi, and intracellular para-
sites [34-36]. A third population of regulatory cells,
Foxp3
+CD8
+ regulatory lymphocytes has also been
described [37-40]. The derivation of Foxp3
+CD8
+ regu-
latory lymphocytes is not completely understood, how-
ever like their CD4
+Foxp3
+ counterparts, it is plausible
that there is both a “natural” and “adaptive” subset of
these cells. Foxp3 is a forkhead transcription factor
which binds DNA adjacent to NFAT sites and is essen-
tial to the development of CD4
+CD25
+ regulatory T
cells [41-43]. We and others have shown that Foxp3
expression can be induced in CD4
+CD25
- target cells
under certain conditions and that these induced Foxp3
+
cells exhibit suppressor activity [44,45]. Stable Foxp3
expression is essential for Treg development and func-
tion, but is not exclusive to regulatory T cells, as transi-
ent or unstable Foxp3 expression has been observed in
other T cell subsets, suggesting that Foxp3 may play
other roles in T cell homeostasis [46-48].
Because activated Treg cells are known to induce
anergy in T cell targets and because FIV infection acti-
vates Treg cells, we asked whether activated Treg cells
from FIV
+ cats altered the expression of cyclins, cyclin-
dependent kinases and cyclin-dependent kinase inhibi-
tors that regulate anergy in CD8
+ target cells. In FIV
infection, CD8
+ lymphocytes display an activated pheno-
type, yet have compromised effector function, reminis-
cent of anergy [3,13,14]. It is likely that CD8
+
lymphocytes receive both stimulatory and inhibitory sig-
nals, leading to a complex convergence of intracellular
signaling events. We therefore systematically evaluated
Figure 1 A schematic representation of the relative protein
levels during the normal progression from G1 to S phase of
the cell cycle. In T lymphocytes during the normal progression of
the cell cycle, D cyclins (D2 and D3,D 2 not shown) are expressed
sequentially starting in late G0/early G1. At approximately the same
time the relative level of the CDKI p21
cip1 begins to increase and
then plateaus during late G1/early S phase. p21
cip1 inhibits cyclin E
until the cellular machinery is ready for a synchronized G1 to S
phase transition. Cyclin E levels begin to rise during late G1and peak
during early S phase. Separation of Rb from E2F proteins and
hyperphosphorylation of Rb at multiple sites signals the irreversible
commitment (IC, double line) to S phase and cell cycle progression.
(Note: only the proteins examined in Figures 2-5 are represented
here.)
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effort to determine when and if anergy occurs in CD8
+
lymphocyte targets following their interaction with acti-
vated Treg cells. To further define the relationship
between activated Treg cells and CD8
+ targets in FIV
infected cats, we asked if Treg cells from chronically
infected FIV
+ cats might also induce suppressor function
in CD8
+ target cells following co-culture.
Results
Cyclin D3 production is decreased and cyclin E production
is increased in CD8
+ targets from FIV
+ cats following CD4
+
CD25
+ co-culture
To examine the effect of FIV infection on cell cycle regula-
tory proteins that could explain T cell-mediated anergy,
cyclin D3 was examined first during sequential evaluation
of cell cycle proteins in CD8
+ target cells. In T lympho-
cytes, cyclin D3 typically assembles with CDK4 or CDK6
during mid G1 phase and reaches maximal production dur-
ing late G1/early S phase (Figure 1[28,29]). Lymph node
CD8
+ cells from either FIV
+ or FIV
- cats were untreated or
co-cultured with CD4
+CD25
+ Treg cells. In both FIV
+ and
FIV
- cats, cyclin D3 was modestly reduced in CD8
+ cells
following a twelve hour co-culture with CD4
+CD25
+ Treg
cells (Figure 2, Additional file 1, Table S1).
Because cyclin E emerges in late G1 to facilitate G1 to
S transition, we asked whether there was any change in
cyclin E in CD8
+ targets following CD4
+CD25
+ co-cul-
ture. As shown in Figure 3 and supplemental table 1,
there was a greater than 2 fold increase in cyclin E pro-
duction in CD8
+ targets from FIV
+ cats with a moderate
decrease in cyclin E production in FIV
- control cats.
The CDKI p21
Cip1 is increased in CD8
+ target cells from
chronically infected FIV
+ cats following CD4
+CD25
+ co-
culture
We asked if activated Treg cells from FIV-infected cats
might induce CDKI production in lymphocyte targets,
because increased CDKI production correlates with cell
cycle arrest in lymphocytes [28,29,49,50]. The Ink 4
family of CDKIs, such as p15
Ink4b, can antagonize the
assembly of cyclin D-dependent kinases [29]. The Cip/Kip
family of CDKIs includes p21
Cip1 and p27
Kip1 which bind
cyclins D, E, and A [29]. The CDKI p21
Cip1 helps control
the activation and survival of autoreactive T cells and
overproduction is associated with G1 cell cycle arrest
[28,50,51]. There was greater than a 1.5 fold increase in
p21
Cip1 in CD8
+ targets from FIV
+ cats following a twelve-
hour CD4
+CD25
+ co-culture, while only a slight reduction
in p21
Cip1 was observed in CD8
+ targets from FIV
- cats
following a twelve-hour CD4
+CD25
+ co-culture (Figure 4,
Additional file 1, Table S1). The levels of both p15
Ink4b
and p27
Kip1 production in CD8
+ targets following CD4
+CD25
+ co-culture were unchanged (Additional file 2,
Figure S1).
Hyperphosphorylation of Rb is not evident in CD8
+ target
cells following CD4
+CD25
+ co-culture
Collectively, the results of Figures 2, 3 and 4 demon-
strate that cyclin D3 levels have declined while cyclin E
Figure 2 CD8
+ lymphocyte Cyclin D3 production in FIV
+ and
FIV
- cats following CD4
+CD25
+ co-culture. Cyclin D3 typically
assembles with CDK4 or CDK6 during mid G1 phase and reaches
maximal production during late G1/early S phase. CD8
+ LN cells
from either FIV
+ (left) or FIV
- (right) cats were either untreated (first
column), or co-cultured with autologous CD4
+CD25
+ Treg cells
(second column). Shown above is a representative blot for
experiments from FIV
+ (n = 4) and FIV
- (n = 2) cats. In both FIV
+
and FIV
- control cats, the mean cyclin D3 production was reduced
following a twelve hour incubation with CD4
+CD25
+ Treg cells.
Figure 3 CD8
+ lymphocyte Cyclin E production in FIV
+ and FIV
-
cats following CD4
+CD25
+ co-culture. Cyclin E production begins
during late G1 phase and peaks during early to mid S phase. CD8
+ LN
cells from either FIV
+ (left) or FIV
- (right) cats were either untreated (first
column) or co-cultured with autologous CD4
+CD25
+ Treg cells (second
column). Shown above is a representative blot for experiments from FIV
+
(n = 4) and FIV
- (n = 2) cats. The mean cyclin E production was increased
greater than two-fold in FIV
+ cats following a twelve hour CD4
+CD25
+
co-culture and decreased approximately one-fold in FIV
- cats.
Figure 4 CD8
+ lymphocyte p21
cip1 production in FIV
+ and FIV
-
cats following CD4
+CD25
+ co-culture. Levels of the CDKI p21
cip1
begin to increase during G0 phase and reach maximal production in
late G1/early S phase. However, p21
cip1 is also increased in anergic T
cells; thereby preventing the G to S phase transition. CD8
+ LN cells
from either FIV
+ (left) or FIV
- (right) cats were either untreated (first
column) or co-cultured with autologous CD4
+CD25
+ Treg cells
(second column). Shown above is a representative blot for
experiments from FIV
+ (n = 4) and FIV
- (n = 2) cats. p21
cip1
production was increased by approximately 1.7 fold in FIV
+ cats
following a twelve hour CD4
+CD25
+ co-culture.
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Cip1 levels have increased. This profile could be
consistent with one of two outcomes: either the target
cell has progressed to S phase or the cell has undergone
late G1 cell cycle arrest. In an effort to clearly delineate
late G1 cell cycle arrest from early S phase transition,
we examined Rb phosphorylation status. Hyperpho-
sphorylation of Rb allows release of the E2F family of
transcription factors and signals irreversible S phase
commitment [27,29]. Rb protein hyperphosphorylation
was not evident in CD8
+ target cells following an eigh-
teen hour CD4
+CD25
+ co-culture (Figure 5, Additional
f i l e1 ,T a b l eS 1 ) .I ns u m ,t h ef i n d i n g so fF i g u r e s2 ,3 ,4
and 5 are most consistent with CD4
+CD25
+ Treg-
induced anergy in CD8
+ target cells from FIV
+ cats
(Figure 6).
IL-2 mRNA expression is reduced in CD8
+ target cells
from chronically infected FIV
+ cats following CD4
+CD25
+
co-culture
Lymphocyte activation is regulated by cyclin-dependent
kinases that stimulate the production of IL-2 mRNA
[27,28,50,52,53]. Autocrine and paracrine production of
IL-2 is critical to lymphocyte expansion, differentiation,
and the avoidance of anergy [54-57]. Therefore, we
examined IL-2 mRNA to validate the findings in Figures
2, 3, 4, 5 and 6. There was a greater than four-fold
r e d u c t i o ni nI L - 2m R N Ai ns t i m u l a t e dC D 8
+ lympho-
cytes from FIV
+ cats following CD4
+CD25
+ co-culture
as compared to stimulated CD8
+ lymphocytes alone,
consistent with the induction of anergy (Figure 7).
Foxp3 expression is increased in CD8
+ targets from FIV
+
cats following CD4
+CD25
+ co-culture, but CD8
+ target
cells lack suppressor function
We asked whether the CD8
+ target cells from FIV
+ cats
shown in Figures 2, 3, 4, 5, 6 and 7 might upregulate
Foxp3 and exhibit suppression of autologous CD8
+
responses. As shown in Figure 8a, Foxp3 induction in
FIV
+ cats was maximal in ConA stimulated (5 ug/ml),
CD8
+ lymphocytes following a 24 hour CD4
+CD25
+ co-
culture (p < 0.05). Foxp3 levels did not increase any
further following a 48 hour co-culture (data not shown).
To assess suppressive potential following co-culture,
CD8
+ target cells and CD4
+CD25
+ Treg cells were then
Figure 5 CD8
+ lymphocyte Rb phosphorylation in FIV
+ and FIV
-
cats following CD4
+CD25
+ co-culture. Hyperphosphorylation of
Rb by cyclin/CDK complexes and subsequent separation of E2F
proteins from Rb signals the irreversible commitment of the cell to
S phase; while lack of Rb phosphorylation suggest either quiescence
(G0) or anergy (G1 cell cycle arrest). As depicted here, CD8
+ LN cells
from either FIV
+ (left) or FIV
- (right) cats were either untreated (first
column), or co-cultured with autologous CD4
+CD25
+ Treg cells
(second column). Shown above is a representative blot for
experiments from FIV
+ (n = 4) and FIV
- (n = 2) cats. There was a
lack of Rb phosphorylation in both FIV
+ and FIV
- cats following an
eighteen hour CD4
+CD25
+ co-culture.
Figure 6 A summary of the relative production levels of
Cyclins D and E, the CDKI p21
cip1, and Rb in CD8
+ lymphocytes
from FIV
+ and FIV
- cats following CD4
+CD25
+ co-culture. FIV
+
cats exhibit a decrease in cyclin D3 with increases in both cyclin E
and p21
cip1. This pattern is consistent with a cell that is in either
late G1 or early S phase of the cell cycle (as shown in Figure 1). The
lack of Rb phosphorylation suggests that the CD8
+ lymphocytes
from FIV
+ cats are in late G1 cell cycle arrest following co-culture
with activated CD4
+CD25
+ lymphocytes. For FIV
+ cats, each bar
represents the mean (+ SEM) of four separate experiments, for FIV
-
cats each bar represents the mean of two separate experiments.
Figure 7 IL-2 mRNA is decreased in CD8
+ lymphocyte targets
following CD4
+CD25
+ co-culture. CD8
+ lymphocytes from FIV
- or
FIV
+ cats were either untreated, ConA stimulated (5 ug/ml), or CD8
+
targets were ConA stimulated for two hours prior to autologous
CD4
+CD25
+ Treg co-culture. After twenty-four hours, RNA was
isolated and reverse transcription RT PCR was performed on all
sample groups. For the CD8
+/CD4
+CD25
+ co-culture, CD4
+CD25
+
cells were depleted by FACS prior to RNA isolation. IL-2 mRNA was
decreased by approximately four-fold in ConA stimulated, CD8
+
lymphocytes from FIV
+ cats following CD4
+CD25
+ co-culture (p <
0.05, arrows). Each bar represents the mean + SEM for six
experiments.
Fogle et al. Retrovirology 2010, 7:97
http://www.retrovirology.com/content/7/1/97
Page 4 of 10re-sorted and combined with autologous CD8
+ lympho-
cytes to assay IFNg production. Figure 8b demonstrates
that CD4
+CD25
+ cells from FIV
+ cats inhibited CD8
+
IFNg spot forming cells (SFCs) by approximately
twenty-five percent. However, in the same experiment,
CD8
+ lymphocytes previously co-cultured with the same
CD4
+CD25
+ cells lacked suppressor function despite
upregulation of Foxp3.
Discussion
The mechanisms underlying T cell immune dysfunc-
tion during the course of AIDS lentiviral infections are
still not completely understood. One of the more puz-
zling aspects of these infections is the presence of lym-
phocytes that appear to be activated yet exhibit
compromised effector function [14,58]. This laboratory
and others have documented Treg mediated immune
suppression of both CD4
+CD25
- and CD8
+ lympho-
cytes during acute and chronic AIDS lentiviral infec-
tion [1-3,7,8]. Based upon these data, the authors have
explored the intracellular events in the CD8
+ target
cells, following co-culture with CD4
+CD25
+ Treg cells,
for a clearer understanding of what may contribute to
CD8
+ immune dysfunction. As CD8
+ lymphocytes
are important for both the elimination of acute viral
infections and control of chronic viral infections,
understanding Treg-mediated CD8
+ anergy may be
one of the keys to understanding AIDS associated
immune dysfunction.
As T cell anergy appears to be an important compo-
nent to virus induced immune dysfunction, we studied
production of molecules that regulate both cell cycle
progression and cellular anergy. Because the control of
cell cycle progression versus cell cycle anergy is regu-
lated by the relative production of selected cell cycle
proteins during the G1 to S phase transition; we exam-
ined a number of these proteins in CD8
+ T cells aner-
gized by contact with activated CD4
+CD25
+ Treg cells
from FIV infected cats. As shown in Figure 2, there was
a modest decrease in cyclin D3 following a twelve hour
Treg co-culture. In general, cyclin D3 levels are expected
to increase during the progression from G1 to S phase,
suggesting that the CD8
+ target cells had either pro-
gressed well into S phase, or had begun G1 cell cycle
arrest [28]. Cyclin E emerges during the progression
from G1 to S phase and Figure 3 clearly shows an
increase in cyclin E in FIV
+ cats following a twelve hour
Treg co-culture, while there was a moderate decrease in
cyclin E in FIV
- cats. Cyclin A emerges during early S
phase and progressively increases during S phase [28].
There was no change in cyclin A activity evident follow-
ing an eighteen hour Treg co-culture. The lack of
Figure 8 CD4
+CD25
+ Treg cells induce Foxp3 expression but not suppressor function in CD8
+ lymphocyte targets.( A ) .C D 8
+
lymphocytes from FIV
- or FIV
+ cats were either untreated, ConA stimulated (5 ug/ml) or ConA stimulated for two hours then co-cultured with
autologous CD4
+CD25
+ Treg cells for twenty-four hours. After twenty-four hours, RNA was isolated and reverse transcription RT PCR was
performed on all sample groups. For the CD8
+/CD4
+CD25
+ co-cultures, CD4
+CD25
+ cells were depleted by FACS prior to RNA isolation. Foxp3
induction was significantly higher in all treatment groups from FIV
+ cats when compared to FIV
- cats (asterisks, p < 0.05) and in ConA
stimulated, CD8
+ lymphocytes following CD4
+CD25
+ co- culture when compared to ConA stimulation alone (p < 0.05 arrows). Each bar
represents the mean + SEM for six experiments. (B). CD8
+ lymphocytes from FIV
+ cats were ConA stimulated then co-cultured with autologous
CD4
+CD25
+ cells to induce Foxp3 expression as described in part A. Following co-culture, CD4
+CD25
+ cells and CD8
+ target cells were re-sorted
and then co-cultured with ConA stimulated (2 hours before co-culture), autologous CD8
+ lymphocytes for forty-eight hours in IFNg ELISpot
plates. Percent suppression was calculated by the following: ConA stimulated CD8
+ lymphocyte SFCs ÷ ConA stimulated CD8
+ lymphocytes +
Foxp3
+ CD8
+ lymphocytes SFCs or ConA stimulated CD8
+ lymphocyte SFCs ÷ ConA stimulated CD8
+ lymphocytes + CD4
+CD25
+ lymphocytes
SFCs. The box-whisker plots represent 5th and 95th percentiles (whisker), 25th and 75th percentiles (box) and median of percent suppression,
dots represent individual cats. There was little suppression evident when CD8
+ targets were co-cultured with Foxp3
+CD8
+ cells. As expected,
CD4
+CD25
+ lymphocytes suppressed IFNg production in CD8
+ targets (p < 0.01, asterisks).
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very late G1 cell cycle arrest (Additional file 2, Figure S1).
Next, the CDKI p21
cip1 was examined. This CDKI is
reported to have a complex role in cell cycle regulation
by facilitating the activity of the D cyclin family, while
inhibiting the activity of cyclin E [28,49]. As shown in
Figure 4 and Figure 6, in CD8
+ target cells from FIV
+
cats, p21
cip1 was increased by approximately 1.7 fold, fol-
lowing co-culture with CD4
+CD25
+ Treg cells. During
the course of G1 progression, Rb is sequentially phos-
phorylated at different sites by cyclin/CDK complexes,
which facilitates the release of E2F transcription factors,
marking the irreversible commitment to S phase [29].
Therefore, increases in intracellular cyclin E, should be
followed by Rb hyperphosphorylation if the cell pro-
gresses into S phase. As shown in Figure 5, there was no
Rb hyper-phosphorylation evident following Treg co-cul-
ture, suggesting that both cyclin D and cyclin E failed to
phosphorylate Rb.
In fibroblasts and CD4
+ lymphocytes during normal
cell cycle progression, p21
cip1 reaches maximal produc-
tion levels during S phase [28,59]. However, in different
models of liver disease, increased p21
cip1 production is
associated with G1 cell cycle arrest [60]. Conversely,
p21
cip1 knockout mice exhibit shorter G1 to S phase
transition times and greater proliferative capacity [49]. A
recent report by Bergamashi et al [61] has demonstrated
increased p21
cip1 production in macrophages from HIV-
infected individuals that may be associated with inhibi-
tion of viral replication within the macrophage. These
findings suggest that increased p21
cip1 production in
CD8
+ targets is likely associated with late G1 cell cycle
arrest. The upregulation of p21
cip1 may provide a benefi-
cial effect to the host by creating a poor environment
for viral replication while conversely contributing to the
development of immunodeficiency by halting CD8
+
effector and proliferative responses.
The findings in Figures 2, 3, 4, 5 and 6 are consistent
with late G1 cell cycle arrest and anergy. To further
characterize this interaction, we asked if Treg cells from
FIV
+ cats would suppress IL-2 mRNA expression in
autologous CD8
+ t a r g e t s .T h ea b i l i t yt op r o d u c eI L - 2i s
a reflection of lymphocyte activation, because it requires
a convergence of intracellular events, including cyclin-
dependent kinase activation of E2F transcription factors
[27,28,50,52,53]. Initially, exogenous signals are critical
to stimulating the CD8
+ cell to produce IL-2 for lym-
phocyte expansion, differentiation, and the avoidance of
anergy [54-57]. As shown in Figure 7, CD8
+ lympho-
cytes were stimulated with ConA to promote IL-2 pro-
duction. Lymphocytes from FIV
- cats exhibited very
modest increases in IL-2 mRNA following ConA stimu-
lation, likely because these cats were SPF animals with
little antigenic exposure and a relatively quiescent
immune system. This is similar to our previous observa-
tion that CD8
+ lymphocytes from FIV
-, SPF cats pro-
duce very little IFNg mRNA following ConA stimulation
[3]. The CD8
+ lymphocytes from FIV
+ cats exhibited a
marked increase in IL-2 mRNA following ConA stimu-
lation which was then markedly decreased following co-
culture with CD4
+CD25
+ Treg cells. Taken together, the
findings of decreased cyclin D3 production, increased
cyclin E and p21
cip1 production, lack of cyclin A pro-
duction, lack of Rb phosphorylation, combined with
suppression of IL-2 mRNA in CD8
+ targets suggests
that Treg cells from FIV
+ c a t sa r ea b l et oi n d u c ev e r y
late G1 cell cycle arrest in CD8
+ targets. This also may
help to explain, in part, why CD8
+ lymphocytes from
FIV
+ cats display an activated phenotype yet have mar-
ginal effector function.
There is a degree of plasticity in T helper versus Treg
phenotype and function; for example, under appropriate
stimulating conditions, CD4
+ T cells exhibiting T helper
phenotype and function can be converted into Treg (or
Treg “like”) cells [44,45]. As demonstrated in murine
models and in FIV infection, these converted cells
express Foxp3 and suppress T helper effector responses
[44,45]. There is also evidence for expansion of CD8
+Foxp3
+ suppressor cells in the SIV lentivirus model
[40]. Therefore, we asked if Foxp3 might also be up-
regulated in CD8
+ targets from FIV
+ cats following Treg
co-culture. We observed CD8
+ target cell up-regulation
of Foxp3 following CD4
+CD25
+ co-culture, however,
these target cells lacked suppressor function (Figure 8).
Our results are consistent with those also reported by
Dieckmann et al. [62] who demonstrated that activated
Treg cells co-cultured with CD8
+ target cells suppressed
effector function and induced anergy in CD8
+ targets,
but did not convert these cells into CD8
+ suppressor
cells. Recent reports demonstrate that Foxp3 expression
can be transiently induced in human CD4
+ and CD8
+ T
lymphocyte targets without these cells exhibiting regula-
tory function; however, the function of Foxp3 in these
target cells in unclear [46-48]. Further investigation is
needed to clarify the role of Foxp3 expression in these
cells.
Conclusions
Analysis of proteins involved in cell cycle regulation is
consistent with late G1 cell cycle arrest in CD8
+ targets
from FIV
+ cats following CD4
+CD25
+/CD8
+ co-culture
(Figures 2, 3, 4, 5 and 6). Figure 7 clearly shows Treg-
mediated suppression of IL-2 mRNA production in CD8
+ targets and we have recently reported reduced IFNg
production in CD8
+ target cells from FIV
+ cats follow-
ing CD4
+CD25
+ Treg co-culture [3]. Collectively, these
data suggest Treg-mediated inhibition of both effector
and proliferative functions in CD8
+ targets from FIV
+
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+CD25
+ Treg cells
are activated early and progressively during the course
of FIV infection and that inhibition of CD4
+CD25
- and
CD8
+ effector responses occurs early and progressively
during the course of FIV infection [1-3]. Further under-
standing of how Treg cells inhibit CD8
+ antiviral func-
tion and CD4
+ T helper function during the course of
FIV infection will help to clarify how lentiviruses estab-
lish and maintain a persistent infection and may offer
insight into the development of novel vaccination and
treatment strategies.
Methods
Cats
Specific pathogen free (SPF) cats were obtained from
Liberty Research, Inc. (Waverly, NY) and housed in the
Laboratory Animal Resource Facility at the College of
Veterinary Medicine, North Carolina State University.
FIV infected cats were housed separately from unin-
fected control cats. Protocols were approved by the
North Carolina State University Institutional Animal
Care and Use Committee.
Infection with FIV
The NCSU1 isolate of FIV was originally obtained from
a naturally infected cat at the North Carolina State Uni-
versity College of Veterinary Medicine and has been
described in detail elsewhere [63]. Virus inoculum was
grown as a single tissue culture passage in an IL2-
dependent feline CD4
+ cell line (FCD4-Ecells) as pre-
viously described [64]. The cats were infected intrave-
nously with 1 × 10
5 TCID50 of cell-free virus culture
and FIV infection was confirmed on serum samples by
using a commercially available ELISA Kit (IDEXX
Laboratories). The cats had been infected for approxi-
mately 2 years prior to these experiments. Plasma vire-
mia was not assessed at the time of lymphocyte
collection for the experiments outlined in Figures 2, 3,
4, 5, 6, 7 and 8. The FIV
+ cats in this study had normal
lymphocyte counts (mean = 2812/μl) with an inverted
CD4:CD8 ratio (mean = 0.61). Control cats were age
matched uninfected SPF cats.
Sample collection
Lymphocytes were harvested either by LN excision or
following euthanasia. Lymph node biopsies were per-
formed as previously described [2,65]. Following collec-
tion, lymph nodes were processed into a single cell
suspension for purification of lymphocyte subsets.
Antibodies
Murine monoclonal anti-feline CD4 (mAb 30A), CD8
(mAb 3.357) and CD25 (mAb 9F23) were produced in
our laboratory [66]. The anti-feline CD25 (mAb 9F23)
was originally provided by K. Ohno (University of
Tokyo). The antibodies were conjugated to FITC (anti-
CD8, anti-CD25), PE (anti-CD4, anti-CD8) or biotin
(anti-CD8) (developed with Streptavidin/PerCP).
Lymphocyte sorting and culture
Lymphocytes were sorted into CD8
+ and CD4
+CD25
+
populations by FACS, using a Moflo high speed cell sor-
ter. Populations were ~99% pure. Lymphocyte cultures
were maintained in serum restricted media (1.0% FBS)
in 12 well, flat bottom plates. Following CD8
+/CD4
+
CD25
+ co-cultures, CD8
+ and CD4
+CD25
+ cells were
then re-sorted by FACS and examined by western blot,
PCR or ELISpot.
Reverse transcription real time PCR
2×1 0
6 CD8
+ lymphocytes from FIV
- and FIV
+ cats
were untreated, ConA stimulated (5 ug/ml) for two
hours and washed, or ConA stimulated for two hours
a n dw a s h e df o l l o w e db yc o - c u l t u r ew i t hC D 4
+CD25
+
cells for 24 hrs (CD4
+CD25
+ to CD8
+ ratio = 1:1). Fol-
lowing CD8
+/CD4
+CD25
+ co-cultures, CD8
+ and CD4
+
CD25
+ cells were then re-sorted by FACS. RNA from
cell cultures was isolated using the Qiagen RNeasy plus
Mini Kit and reverse transcription was performed using
the Promega Reverse Transcription System, following
the manufacturer’s instructions for both. This reaction
was followed by a real-time PCR step using the universal
Taqman PCR Mastermix (Applied Biosystems) and the
Qiagen Quantitect Sybr Green PCR Kit (probe). The
reactions were run in duplicates in 96 well plates. The
fold induction was calculated by using the ΔΔCt value,
where Fold Induction = 2 - (ΔΔCt), as described by
Winer et al [67]. PBMCs from an FIV negative cat and
GAPDH as the internal control were used as the calibra-
tion sample value in the ΔΔCt equation. The feline spe-
cific IL-2, Foxp3, and GAPDH primer sequences utilized
for the real time PCR reaction were as follows: IL-2 (for-
ward ACA GTG CAC CTG CTT CAA GCT CT-3’ and
reverse CCT GGA GAG TTT GGG GTT CTC AGG),
Foxp3 (forward GCC TGC CAC CTG GAA TCA AC
and reverse GTG TGC TGG GGC TTG GGA), and
GAPDH (forward GGA GAA GGC TGG GGC TCA C
and reverse GGT GCA GGA GGC ATT GCT GA).
Western Blotting
Approximately 4 × 10
6 CD8
+ FACS purified CD8
+ and
CD4
+CD25
+ lymphocytes were harvested for each treat-
ment group. For co-culture experiments, CD8
+ and CD4
+
CD25
+ were co-cultured at a 1:1 ratio and then re-sorted
using FACS (~99% purity). The CD8
+ cells were then
lysed with NP-40 and separated by SDS-Page. The blots
were analyzed using anti-cyclin D3 (Cell Signaling
Technologies #2936), anti-Cyclin E (Cell Signaling
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#NB-120-14061), and anti-Rb (Cell Signaling Technologies
#9308), followed by HRP-conjugated goat anti-mouse
IgG1 and detected by chemiluminescence. The blots were
then stripped and re-probed with anti-actin and HRP-
conjugated goat anti-mouse. For each treatment group,
actin and the protein in question were evaluated by photo-
densitometry and normalized using the VersaDoc imaging
system (Bio-Rad Laboratories). For reporting of fold
change, each treatment group was compared to unstimu-
lated CD8
+ controls which were assigned a value of 1.
IFNg ELISpot
Following co-culture, CD4
+CD25
+ cells and CD8
+ target
cells were re-sorted, assessed by trypan blue staining for
viability (<10% positive), and then cultured alone (2.5 ×
10
5 per well) or co-cultured with ConA stimulated auto-
logous CD8
+ lymphocytes (1:1 ratio) for 48 hrs in pre-
coated 96 well ELISpot plates (monoclonal anti-feline
IFNg, R and D systems). The ConA stimulated CD8
+
lymphocyte targets were stimulated for two hours then
washed prior to co-culture. The plates were incubated
for 24 hours, stained with detection antibody, and devel-
oped per the manufacturer’s instructions. Once dry,
each well was counted with an automated ELISpot
reader for quantification of spot forming cells (SFC) per
number of cells plated in each well. Percent suppression
was calculated by the following: (1) ConA stimulated
CD8
+ lymphocyte SFCs ÷ ConA stimulated CD8
+ lym-
phocytes + Foxp3
+ CD8
+ lymphocytes SFCs or (2)
ConA stimulated CD8
+ lymphocyte SFCs ÷ ConA sti-
mulated CD8
+ lymphocytes + CD4
+CD25
+ lymphocytes
SFCs. CD4
+CD25
+ lymphocytes alone and CD8
+Foxp3
+
alone did not produce any IFNg SFCs.
Additional material
Additional File 1: Table S1: Fold change in the production of cyclins
D and E, the CDKI p21
cip1, and Rb in CD8
+ lymphocytes from FIV
+
and FIV
- cats following CD4
+CD25
+ co-culture. The values (rows) for
individual FIV
+ (n = 4) and FIV
- (n = 2) cats are shown for each protein
(columns). The last value for each group is the mean fold change. As
reported in the methods, the fold change in CD8
+ target cells was
calculated by comparing the protein in question following co-culture to
CD8
+ target cells alone.
Additional File 2: Figure S1: Cyclin A, p15
Ink4b and p27
Kip1 protein
production in CD8
+ lymphocytes following CD4
+CD25
+ co-culture.
The levels of these three proteins remained unchanged in CD8
+ targets
following CD4
+CD25
+ co-culture. The results are representative of two
(cyclin A) or four (p15
Ink4b and p27
Kip1) separate experiments from FIV
+
cats.
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